Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Author Archives: MissionIR

MissionIRNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Advancing Novel Immunotherapy to Combat Antibiotic Resistance

Posted on June 30, 2025 by MissionIR

Soligenix (NASDAQ: SNGX) is at the forefront of the effort as the medical community urgently seeks alternative treatments for bacterial infections in the face of escalating antibiotic resistance. The company’s SGX943 therapy “is based on dusquetide, an Innate Defense Regulator (‘IDR’) … Continue reading →

Posted in Soligenix Inc. SNGX | Leave a comment

MissionIRNewsBreaks – Why Lantern Pharma Inc. (NASDAQ: LTRN) Is ‘One to Watch’

Posted on June 30, 2025 by MissionIR

Lantern Pharma (NASDAQ: LTRN), a clinical-stage biotechnology company, is leveraging artificial intelligence and machine learning to redefine oncology drug development. Through its proprietary platform, RADR(R) (Response Algorithm for Drug Positioning & Rescue), Lantern is advancing a pipeline of precision cancer … Continue reading →

Posted in Lantern Pharma Inc. LTRN | Leave a comment

MissionIRNewsBreaks – Clene Inc. (NASDAQ: CLNN) Advances Regulatory Strategy for CNM-Au8 with FDA Meetings Scheduled for ALS and MS Programs

Posted on June 30, 2025 by MissionIR

Clene (NASDAQ: CLNN) announced key regulatory developments following a Type C meeting with the FDA, where it received feedback on its statistical analysis plan (SAP) for evaluating neurofilament light (NfL) biomarker data from its Expanded Access Protocol for ALS. The company … Continue reading →

Posted in Clene Inc. CLNN | Leave a comment

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Breaks Ground on REE Processing Facility, Pioneers Domestic Supply Chain

Posted on June 27, 2025 by MissionIR

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF), a critical metals technology company developing scalable rare earth element (“REE”) refining infrastructure in North America, has marked a significant milestone in the development of a domestic REE supply chain. The company announced … Continue reading →

Posted in Ucore Rare Metals Inc. UURAF | Leave a comment

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Applies for FDA Commissioner’s National Priority Voucher for IV Ketamine NRX-100

Posted on June 27, 2025 by MissionIR

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company developing innovative treatments for suicidal depression and PTSD, is accelerating its push toward regulatory approval of NRX-100, a preservative-free intravenous ketamine formulation. The company has filed an application under the newly created … Continue reading →

Posted in NRx Pharmaceuticals Inc. NRXP | Leave a comment

MissionIRNewsBreaks – Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Advancing Strategic Path in Resurging Market

Posted on June 26, 2025 by MissionIR

Platinum Group Metals (NYSE American: PLG) (TSX: PTM) is well positioned as platinum and palladium prices have gained considerable momentum in recent weeks, driven largely by a resurgence in demand from China’s jewelry sector and increasing concern over global supply constraints. … Continue reading →

Posted in Platinum Group Metals Ltd. PLG | Leave a comment

Lantern Pharma Inc.’s (NASDAQ: LTRN) AI-Powered Platform Delivers Promising and Durable Results in Lung Cancer Trial

Posted on June 26, 2025 by MissionIR

Lantern Pharma (NASDAQ: LTRN), a clinical-stage biotechnology company leveraging artificial intelligence and machine learning to redefine oncology drug development, recently reported an encouraging clinical outcome in its Phase 2 HARMONIC(TM) trial, where a patient with advanced non-small cell lung cancer … Continue reading →

Posted in Lantern Pharma Inc. LTRN | Leave a comment

MissionIRNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Highlights PC111 Breakthrough After Scientist Wins Top Italian Dermatology Award

Posted on June 26, 2025 by MissionIR

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharma company focused on inflammation and immunology, announced that Dr. Roberta Lotti of Pincell Srl has won the “Oscar of Italian Dermatology” from SIDeMaST for her research on PC111, a first-in-class anti-Fas Ligand monoclonal antibody. … Continue reading →

Posted in Scinai Immunotherapeutics Ltd. SCNI | Leave a comment

MissionIRNewsBreaks – FAVO Capital Inc. (FAVO) Eyes Opportunity at Crossroads of Fintech Innovation, Lending Demand

Posted on June 25, 2025 by MissionIR

As traditional banks retreat from Main Street, alternative lenders are stepping up to fill the gap, reshaping the $1.7 trillion small business lending market. With policymakers calling for renewed focus on small business financing and digital platforms redefining borrower access, … Continue reading →

Posted in FAVO Capital Inc. FAVO | Leave a comment

Silvercorp Metals Inc. (NYSE-A: SVM) (TSX: SVM) Reports Record Q4 Results and Strong Cash Flow for Fiscal 2025

Posted on June 25, 2025 by MissionIR

Silvercorp Metals (NYSE-A: SVM) (TSX: SVM), a Canadian mining company producing silver, gold, lead, and zinc, with a long history of profitability, delivered its strongest fourth-quarter performance to date, closing out Fiscal 2025, ended March, with significant growth in both … Continue reading →

Posted in Silvercorp Metals Inc. SVM | Leave a comment